tiprankstipranks
Advertisement
Advertisement

CMPS Stock Latest News

Trump Trade: President to sign order on psychedelic used for PTSD
The FlyTrump Trade: President to sign order on psychedelic used for PTSD
5h ago
PBM
SPY
Trump to sign order on psychedelic used for PTSD, CBS News says
PremiumThe Fly
Trump to sign order on psychedelic used for PTSD, CBS News says
1d ago
PBM
ATAI
Psychedelic: Clearmind’s CMND-100 meets primary endpoint in trial
PremiumThe Fly
Psychedelic: Clearmind’s CMND-100 meets primary endpoint in trial
1d ago
BMY
CMND
Strong Efficacy, Favorable Safety, and Limited Competition Drive Buy Rating on COMPASS Pathways’ COMP360
PremiumRatings
Strong Efficacy, Favorable Safety, and Limited Competition Drive Buy Rating on COMPASS Pathways’ COMP360
17d ago
CMPS
Compass Pathways: Strengthened Balance Sheet, Advancing COMP360 Through Pivotal Milestones Supports Buy Rating
PremiumRatings
Compass Pathways: Strengthened Balance Sheet, Advancing COMP360 Through Pivotal Milestones Supports Buy Rating
21d ago
CMPS
Psychedelic: Compass Pathways, NRx Pharma report earnings results
PremiumThe FlyPsychedelic: Compass Pathways, NRx Pharma report earnings results
22d ago
ATAI
CMPS
Compass Pathways price target lowered to $18 from $20 at Canaccord
Premium
The Fly
Compass Pathways price target lowered to $18 from $20 at Canaccord
23d ago
CMPS
Compass Pathways price target raised to $14 from $11 at Stifel
Premium
The Fly
Compass Pathways price target raised to $14 from $11 at Stifel
23d ago
CMPS
Compass Pathways price target lowered to $16 from $18 at Morgan Stanley
PremiumThe Fly
Compass Pathways price target lowered to $16 from $18 at Morgan Stanley
23d ago
CMPS
Compass Pathways reports Q4 EPS ($1.00) vs. (63c) last year
PremiumThe Fly
Compass Pathways reports Q4 EPS ($1.00) vs. (63c) last year
24d ago
CMPS
Compass Pathways sees cash runway into 2028
PremiumThe Fly
Compass Pathways sees cash runway into 2028
24d ago
CMPS
Neuronetics price target lowered to $3 from $7 at Canaccord
PremiumThe Fly
Neuronetics price target lowered to $3 from $7 at Canaccord
29d ago
CMPS
STIM
COMPASS Pathways: Durable Psychedelic Therapy Profile and Clear Path to 2027 Approval Support Buy Rating
PremiumRatingsCOMPASS Pathways: Durable Psychedelic Therapy Profile and Clear Path to 2027 Approval Support Buy Rating
1M ago
CMPS
3 Best Stocks to Buy in Today’s Volatile Market, 3/4/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy in Today’s Volatile Market, 3/4/2026, According to Top Analysts
1M ago
BOBS
CMPS
Cathie Wood Scoops Up $24M in Figma, Sells DraftKings
Premium
Market News
Cathie Wood Scoops Up $24M in Figma, Sells DraftKings
2M ago
FIG
ARKG
Psychedelic: Exclusive talk with nonprofit organization MAPS
PremiumThe Fly
Psychedelic: Exclusive talk with nonprofit organization MAPS
2M ago
ATAI
CMND
COMPASS Pathways Announces $150 Million Public Offering
PremiumCompany Announcements
COMPASS Pathways Announces $150 Million Public Offering
2M ago
8K
CMPS
Compass Pathways 17.5M share Secondary priced at $8.00
PremiumThe Fly
Compass Pathways 17.5M share Secondary priced at $8.00
2M ago
CMPS
Compass Pathways price target raised to $22 from $21 at RBC Capital
PremiumThe Fly
Compass Pathways price target raised to $22 from $21 at RBC Capital
2M ago
CMPS
Compass Pathways price target raised to $18 from $11 at Morgan Stanley
PremiumThe FlyCompass Pathways price target raised to $18 from $11 at Morgan Stanley
2M ago
CMPS
Compass Pathways price target raised to $20 from $15 at Canaccord
Premium
The Fly
Compass Pathways price target raised to $20 from $15 at Canaccord
2M ago
CMPS
Compass Pathways announces $150M American Depositary Shares offering
Premium
The Fly
Compass Pathways announces $150M American Depositary Shares offering
2M ago
CMPS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >